Huma Therapeutics Acquires Aluna with Strategic Investment from Eckuity Capital

May 16, 2025

Huma Therapeutics has acquired Aluna (also known as Knox Medical Diagnostics, Inc.) and announced a partnership and growth investment from Eckuity Capital to accelerate M&A. The acquisition adds Aluna’s remote respiratory monitoring devices and platform — including FDA-cleared spirometers and a clinician portal — to Huma’s Cloud Platform, expanding Huma’s respiratory capabilities and customer reach across 150+ U.S. health systems.

Buyers
Huma Therapeutics, Eckuity Capital
Targets
Aluna (Knox Medical Diagnostics, Inc.)
Location
California, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.